Apigenin (4',5,7-Trihydroxyflavone) is a competitive CYP2C9 inhibitor with a Ki of 2 μM. It inhibits cytochrome P450 2C9 (CYP2C9) with a Ki of 2 μM in the CYP2C9 RECO system, a purified, reconstituted enzyme system. This natural flavonoid possesses broad biological properties including antioxidative, anti-inflammatory, anticancer, and neuroprotective effects.
- Inhibits cell proliferation
- Suppresses clone formation of SGC-7901 cells
- Alleviates Adriamycin-induced myocardial injury
- Reduces serum aspartate amino transferase (AST) release
- Reduces serum lactate dehydrogenase (LDH) release
- Reduces serum creatine kinase (CK) contents